GSK plc
F:GS70
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GSK plc
F:GS70
|
UK |
|
Plexus Corp
F:PX4
|
US |
|
M
|
Medifast Inc
DUS:MDF
|
US |
|
A
|
Azimut Holding SpA
XBER:HDB
|
IT |
Wall St Price Targets
GS70 Price Targets Summary
GSK plc
According to Wall Street analysts, the average 1-year price target for GS70 is 49.48 EUR with a low forecast of 33.82 EUR and a high forecast of 66.45 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GS70's stock price target?
Price Target
49.48
EUR
According to Wall Street analysts, the average 1-year price target for GS70 is 49.48 EUR with a low forecast of 33.82 EUR and a high forecast of 66.45 EUR.
What is the Revenue forecast for GSK plc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for GSK plc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for GSK plc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 5%.
What is the Pre-Tax Income forecast for GSK plc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for GSK plc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 14%.
